Schonfeld Strategic Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-1,161
| Closed | -$68.2K | – | 2310 |
|
2023
Q4 | $68.2K | Sell |
1,161
-29,539
| -96% | -$1.74M | ﹤0.01% | 1561 |
|
2023
Q3 | $1.34M | Sell |
30,700
-98,936
| -76% | -$4.31M | 0.01% | 810 |
|
2023
Q2 | $4.68M | Buy |
129,636
+106,837
| +469% | +$3.86M | 0.04% | 505 |
|
2023
Q1 | $848K | Buy |
22,799
+14,599
| +178% | +$543K | 0.01% | 1000 |
|
2022
Q4 | $372K | Sell |
8,200
-15,227
| -65% | -$690K | ﹤0.01% | 1671 |
|
2022
Q3 | $1.64M | Sell |
23,427
-8,574
| -27% | -$599K | 0.01% | 964 |
|
2022
Q2 | $2.15M | Buy |
+32,001
| New | +$2.15M | 0.02% | 672 |
|
2022
Q1 | – | Sell |
-16,350
| Closed | -$2.4M | – | 2848 |
|
2021
Q4 | $2.4M | Sell |
16,350
-2,377
| -13% | -$349K | 0.02% | 604 |
|
2021
Q3 | $3.31M | Sell |
18,727
-11,395
| -38% | -$2.02M | 0.03% | 500 |
|
2021
Q2 | $4.87M | Buy |
+30,122
| New | +$4.87M | 0.05% | 448 |
|
2021
Q1 | – | Sell |
-1,692
| Closed | -$373K | – | 2139 |
|
2020
Q4 | $373K | Sell |
1,692
-94
| -5% | -$20.7K | 0.01% | 1093 |
|
2020
Q3 | $297K | Sell |
1,786
-3,793
| -68% | -$631K | 0.01% | 1058 |
|
2020
Q2 | $637K | Sell |
5,579
-11,076
| -67% | -$1.26M | 0.02% | 685 |
|
2020
Q1 | $1.28M | Sell |
16,655
-11,482
| -41% | -$882K | 0.08% | 296 |
|
2019
Q4 | $3.63M | Sell |
28,137
-96,863
| -77% | -$12.5M | 0.09% | 250 |
|
2019
Q3 | $9.74M | Sell |
125,000
-95,400
| -43% | -$7.43M | 0.29% | 101 |
|
2019
Q2 | $22.7M | Buy |
220,400
+59,200
| +37% | +$6.1M | 0.8% | 16 |
|
2019
Q1 | $11.8M | Buy |
161,200
+70,300
| +77% | +$5.15M | 0.41% | 54 |
|
2018
Q4 | $3.86M | Buy |
90,900
+36,400
| +67% | +$1.54M | 0.15% | 192 |
|
2018
Q3 | $2.57M | Sell |
54,500
-34,600
| -39% | -$1.63M | 0.11% | 241 |
|
2018
Q2 | $4.39M | Buy |
+89,100
| New | +$4.39M | 0.24% | 147 |
|
2018
Q1 | – | Sell |
-32,113
| Closed | -$586K | – | 996 |
|
2017
Q4 | $586K | Buy |
+32,113
| New | +$586K | 0.05% | 427 |
|